Evelo Biosciences Inc 's

• EVLO's Stock Performance relative to its Competitors

Myovant Sciences Ltd Share Performance +0.19% This Year

Myovant Sciences Ltd Profile Myovant Sciences Ltd operates under a biopharmaceutical business model primarily focused on the development and commercialization of therapies for women's health and prostate cancer. The company aims to leverage its expertise in clinical research, regulatory affairs, and manufacturing to bring innovative treatments to market and improve patients' lives. Myovant Sciences employs a combination of in-house research and development along with collaboration with strategic partners to advance its pipeline of product candidates. More about Myovant Sciences Ltd 's Market Share

Lexicon Pharmaceuticals Inc Share Performance +84.21% This Year

Lexicon Pharmaceuticals Inc Profile Lexicon Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of innovative drugs. Their business model revolves around identifying potential drug targets, conducting research and preclinical studies to validate these targets, and subsequently developing drugs through clinical trials for various therapeutic areas. They also collaborate with pharmaceutical companies for joint development and commercialization efforts, aiming to bring these drugs to market and improve patient outcomes. More about Lexicon Pharmaceuticals Inc 's Market Share

Therapeuticsmd Inc Share Performance +98.61% One Year

Therapeuticsmd Inc Profile TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women. More about Therapeuticsmd Inc 's Market Share

Legend Biotech Corporation Share Performance -35.28% This Quarter

Legend Biotech Corporation Profile Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases. More about Legend Biotech Corporation's Market Share

Biohaven Ltd Share Performance +5.24% One Year

Biohaven Ltd Profile Biohaven Ltd operates as a pharmaceutical company that focuses on discovering and developing therapies for neurological diseases and rare disorders. Their business model revolves around conducting extensive research and clinical trials to bring innovative treatments to market. By collaborating with healthcare professionals, regulatory agencies, and investors, Biohaven aims to improve the lives of patients suffering from these conditions and provide a significant return on investment for stakeholders. More about Biohaven Ltd 's Market Share

Sources: Evelo Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 19, 2026 5:19 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Evelo Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.